Add to My Stocks
$1.97 $0.06 (2.96%) GNMX stock closing price Mar 21, 2018 (Closing)
Prev Close* : $2.03
Market Cap:
Day Low: $1.97
52 Week Low: $0.98
Open: $2.02
Volume: -
Day High: $2.06
52 Week High: $2.65

Latest Stock Market News

Latest Articles

AEVI GENOMIC News - From Partners

GNMX Stockcharts

View GNMX PE ratio, PS ratio stocks charts and compare with peers.
GNMX Chart
Note: Compare AEVI GENOMIC stock price history with the index and industry peers.


PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio


(return on equity)

AEVI GENOMIC Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

GNMX Industry Peers

Company Price Change (%)
Teligent (TLGT)3.210.11 (3.55%)
Agile Therapeutics (AGRX)2.90.04 (1.4%)
Versartis (VSAR)1.80.1 (5.88%)
Evoke Pharma (EVOK)2.070.09 (4.55%)
Odyssey Marine Exploration (OMEX)3.80.28 (7.95%)
Fibrogen (FGEN)51.050.55 (1.09%)
Akebia Therapeutics (AKBA)120.14 (1.18%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)3.210.11 (3.55%)
Impax Lab (IPXL)20.750.7 (3.49%)
AxoGen (AXGN)39.40.9 (2.34%)
Mylan (MYL)41.160.75 (1.86%)
Aquinox Pharma (AQXP)14.440.16 (1.12%)
Progenics Pharma (PGNX)8.360.09 (1.09%)
Corium (CORI)11.60.08 (0.69%)
Top gainers from Medical-Generic Drugs industry
* As of Mar 22, 2018
CompanyPriceChange (%)
AEVI GENOMIC (GNMX)1.970.06 (2.96%)
Supernus Pharma (SUPN)44.051.3 (2.87%)
Akorn (AKRX)18.60.18 (0.96%)
Adamas Pharma (ADMS)25.80.25 (0.96%)
Teva Pharmaceutical (TEVA)17.60.08 (0.45%)
Dr. Reddy's Laboratories (RDY)33.170.12 (0.36%)
Top losers from Medical-Generic Drugs industry
* As of Mar 22, 2018

AEVI GENOMIC Stock News - Partner Headlines

AEVI GENOMIC Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-41.9M-37.99M-18.43M-17.12M-15.07M
Total Operating Expense41.87M36.56M18.93M17.81M12.62M
View AEVI GENOMIC income statement
balance sheet20162015201420132012
Total Assets40.56M54.25M34.28M23.08M7.7M
Total Liabilities5.58M3.9M4.61M4.66M5.77M
Shareholders Equity34.97M50.35M29.66M18.42M1.93M
View AEVI GENOMIC balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities2.09M-0.1M---
Net Cash from (used by) Operating Activities-32.74M-24.34M-12.19M-12.73M-8.61M
Increase (Decrease) in Prop Plant And Equipment-0.22M-0.18M-0.36M-0.18M-0.06M
View AEVI GENOMIC cash flow statement

AEVI GENOMIC Stock Message Board

As of last trading day, AEVI GENOMIC stock price was $1.97. Looking at AEVI GENOMIC market capitalization, which currently stands at $120.46M, we can say that GNMX stock is a Micro Cap stock. AEVI GENOMIC valuation can be guaged using various valuation metrics like the price to earnings ratio.

For recognizing and analyzing the real performance of AEVI GENOMIC stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 48,647 on the last trading day, as is evident from AEVI GENOMIC stock chart, and GNMX stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. AEVI GENOMIC stock dividend was 0.00 during the last quarter. AEVI GENOMIC stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.